News and Updates
Learn More About the Seraph 100 and OncoBind
For media inquiries, please contact:
Press Releases
ExThera Medical Receives Certification for Medical Device Single Audit Program (MDSAP) and Recertification for International Organization for Standardization for Medical Devices (ISO 13485)
ExThera Medical in Growth Mode after FDA Approval of Investigational Device Exemption
ExThera Medical Announces FDA Approval of IDE Application for Use of the OncoBind™️ Extracorporeal Procedure to Remove Circulating Tumor Cells in Patients with Pancreatic Cancer
ExThera Medical Exhibits at the 2023 International Conference on Extracorporeal Organ Support in Zagreb, Croatia
Brooke Army Medical Center (BAMC) Establishes Clinical Utility of Seraph 100 for Critically Ill Patients Suffering from Septic Shock Caused by Multiple Pathogens Including Candida
ExThera Medical Successfully Completes Phase I of PURIFY RCT: US Investigational Device Exemption Trial Evaluating Seraph 100 for the Treatment of Septic Shock
Extracorporeal Blood Filter Removes Circulating Tumor Cells: Dialysis-like Cell Removal Therapy to be Studied for Treating Metastatic Cancer
ExThera Medical’s CEO Bob Ward Receives Prestigious BioMedSA Award for Innovation in Healthcare and Bioscience Including a Groundbreaking Device to Treat COVID-19
ExThera Medical Wins a Gold Edison Award for COVID-19 Innovations: Therapeutic Impact for the Seraph® 100 Blood Filter
Results Published for Seraph 100 Treatment of COVID-19 Confirm Survival Benefit Signal
PURIFY Investigators Announce First Patient Enrolled in a US Randomized Controlled IDE Trial Evaluating Seraph 100 for the Treatment of Septic Shock
ExThera Medical & Fresenius Medical Care Sign Distribution Agreement for Seraph 100 Blood Purification Device in Mexico
Patient Enrollment is Complete in the DOD-Funded Study of Extracorporeal Hemopurification of Critically Ill COVID-19 Patients
Treatment for critically ill COVID patients results in significant improvement in survival rate according to new study
ExThera Medical and Asahi Kasei Medical Enter into Partnership to Expand Reach of Treatment for the Critically Ill
ExThera and Asahi Kasei Medical secure exclusive distribution agreement in Japan